Cargando…

Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment

Primary campylobacter enteritis with secondary bacteremia was diagnosed in an immunocompromised patient with stage IV gliosarcoma. She developed mild diarrhea followed by systemic symptoms with transient generalized weakness and fever. She was treated with azithromycin and had a full recovery and wi...

Descripción completa

Detalles Bibliográficos
Autor principal: Liu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714086/
https://www.ncbi.nlm.nih.gov/pubmed/23882353
http://dx.doi.org/10.3402/jchimp.v2i1.17217
_version_ 1782476614272024576
author Liu, Ping
author_facet Liu, Ping
author_sort Liu, Ping
collection PubMed
description Primary campylobacter enteritis with secondary bacteremia was diagnosed in an immunocompromised patient with stage IV gliosarcoma. She developed mild diarrhea followed by systemic symptoms with transient generalized weakness and fever. She was treated with azithromycin and had a full recovery and without relapse through 2 months of follow-up. Her diagnosis was confirmed by a positive stool culture for Campylobacter sp. and blood culture for Campylobacter jejuni/coli.
format Online
Article
Text
id pubmed-3714086
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-37140862013-07-23 Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment Liu, Ping J Community Hosp Intern Med Perspect Case Report Primary campylobacter enteritis with secondary bacteremia was diagnosed in an immunocompromised patient with stage IV gliosarcoma. She developed mild diarrhea followed by systemic symptoms with transient generalized weakness and fever. She was treated with azithromycin and had a full recovery and without relapse through 2 months of follow-up. Her diagnosis was confirmed by a positive stool culture for Campylobacter sp. and blood culture for Campylobacter jejuni/coli. Co-Action Publishing 2012-04-30 /pmc/articles/PMC3714086/ /pubmed/23882353 http://dx.doi.org/10.3402/jchimp.v2i1.17217 Text en © 2012 Ping Liu http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Liu, Ping
Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
title Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
title_full Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
title_fullStr Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
title_full_unstemmed Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
title_short Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment
title_sort campylobacteremia in stage iv gliosarcoma with bevacizumab treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714086/
https://www.ncbi.nlm.nih.gov/pubmed/23882353
http://dx.doi.org/10.3402/jchimp.v2i1.17217
work_keys_str_mv AT liuping campylobacteremiainstageivgliosarcomawithbevacizumabtreatment